Fairvalue-Calculator Fairvalue-Calculator
EN DE

Daiken Biomedical Co (7780) Fair Value & Analysis

Consumer Defensive · TW · Market cap 15.1B TWD

Price18.25 TWD
Fair Value8.39 TWD
Upside-54.0%
Quality91/100
Evidence: High Range 6.29 TWD – 10.49 TWD

Analysis

Daiken Biomedical Co (7780) currently trades at 18.25 TWD, while our model-based Fair Value estimate is 8.39 TWD — implying the stock looks roughly 54.0% overvalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Daiken Biomedical Co., Ltd. engages in the research and development of healthy food products. The company was founded in 2018 and is based in Taipei, Taiwan. Daiken Biomedical Co., Ltd. operates as a subsidiary of Sunfun Info Co., Ltd.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NSRGF) -33% Foshan Haitian Flavouring and Food Company (603288) -22% Nestlé India Limited (NESTLEIND) -74% Grupo Bimbo, S.A. (BIMBOA) +26% Uni-President Enterprises Corp (1216) -3% Britannia Industries Limited (BRITANNIA) -64%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.